Showing results (261-270 of 454) with videos related to
Sort By:
Pageof 46
Infection and Drug Resistance|December 7, 2018
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significantCelia Perales, Qian Chen, Maria Eugenia Soria, et al.Journal of Hepatology|July 15, 2024
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtideMaria Buti, Heiner Wedemeyer, Soo Aleman, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2007
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis BEmmet B Keeffe, Stefan Zeuzem, Raymond S Koff, et al.Journal of Hepatology|April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agentXavier Forns, Stuart C Gordon, Eli Zuckerman, et al.Frontiers in Medicine|October 17, 2022
Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney diseaseJavier Naranjo, Francisco Borrego, José Luis Rocha, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGEMaria Buti, Stuart C Gordon, Eli Zuckerman, et al.The Lancet Regional Health. Europe|September 22, 2025
Estimating the impact of displacement from Ukraine on HBV and HCV prevalence among migrants in the European Union, 2024: a modeling studyDevin M Razavi-Shearer, Loreta A Kondili, Samantha Hall, et al.Journal of Clinical Gastroenterology|November 2, 2013
Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic responseStuart C Gordon, K Rajender Reddy, Ira M Jacobson, et al.The American Journal of Gastroenterology|July 9, 2009
Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patientsErik H C J Buster, Hajo J Flink, Halis Simsek, et al.Revista Espanola De Enfermedades Digestivas|September 21, 2020
Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the expertsJosé Luis Calleja-Panero, Raúl J Andrade, Rafael Bañares, et al.Pageof 46